Effects of administration route on uptake kinetics of 18F-sodium fluoride positron emission tomography in mice

被引:0
|
作者
Zaniah N. Gonzalez-Galofre
Carlos J. Alcaide-Corral
Adriana A. S. Tavares
机构
[1] Queen’s Medical Research Institute (QMRI),British Heart Foundation/University of Edinburgh Centre for Cardiovascular Science
[2] University of Edinburgh,Edinburgh Imaging
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
18F-sodium fluoride (18F-NaF) is a positron emission tomography (PET) radiotracer widely used in skeletal imaging and has also been proposed as a biomarker of active calcification in atherosclerosis. Like most PET radiotracers, 18F-NaF is typically administered intravenously. However in small animal research intravenous administrations can be challenging, because partial paravenous injection is common due to the small calibre of the superficial tail veins and repeat administrations via tail veins can lead to tissue injury therefore limiting the total number of longitudinal scanning points. In this paper, the feasibility of using intra-peritoneal route of injection of 8F-NaF to study calcification in mice was studied by looking at the kinetic and uptake profiles of normal soft tissues and bones versus intra-vascular injections. Dynamic PET was performed for 60 min on nineteen isoflurane-anesthetized male Swiss mice after femoral artery (n = 7), femoral vein (n = 6) or intraperitoneal (n = 6) injection of 8F-NaF. PET data were reconstructed and the standardised uptake value (SUV) and standardised uptake value ratio (SUVr) were estimated from the last three frames between 45- and 60-min and 8F-NaF uptake constant (Ki) was derived by Patlak graphical analysis. In soft tissue, the 18F-NaF perfusion phase changes depending on the type on injection route, whereas the uptake phase is similar regardless of the administration route. In bone tissue SUV, SUVr and Ki measures were not significantly different between the three administration routes. Comparison between PET and CT measures showed that bones that had the highest CT density displayed the lowest PET activity and conversely, bones where CT units were low had high 8F-NaF uptake. Intraperitoneal injection is a valid and practical alternative to the intra-vascular injections in small-animal 18F-NaF PET imaging providing equivalent pharmacokinetic data. CT outcome measures report on sites of stablished calcification whereas PET measures sites of higher complexity and active calcification.
引用
收藏
相关论文
共 50 条
  • [21] Clinical Significance of the Assessment of Valvular Calcification Using 18F-sodium Fluoride Positron Emission Tomography
    Aoyama, Rie
    Kameyama, Masashi
    Ishikawa, Joji
    Harada, Kazumasa
    CIRCULATION, 2021, 144
  • [22] Correlation between 18F-Sodium Fluoride positron emission tomography and bone histomorphometry in dialysis patients
    Aaltonen, Louise
    Koivuviita, Niina
    Seppanen, Marko
    Tong, Xiaoyu
    Kroger, Heikki
    Loyttyniemi, Eliisa
    Metsarinne, Kaj
    BONE, 2020, 134
  • [23] Bringing Color to Atherosclerotic Plaque Calcification With 18F-Sodium Fluoride Positron Emission Tomography Imaging
    Fayad, Zahi A.
    Robson, Philip M.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2021, 41 (10) : 2585 - 2587
  • [24] 18F-Sodium Fluoride Positron Emission Tomography An In Vivo Window Into Coronary Atherosclerotic Plaque Biology
    George, Richard T.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (17) : 1549 - 1550
  • [25] 18F-SODIUM FLUORIDE POSITRON EMISSION TOMOGRAPHY, AORTIC DISEASE ACTIVITY AND ISCHAEMIC STROKE RISK
    Fletcher, Alexander
    Tzolos, Evangelos
    Joshi, Shruti
    Kwiecinski, Jacek
    Bing, Rong
    Syed, Maaz
    Doris, Mhairi
    van Beek, Edwin
    Moss, Alistiar
    Walker, Niki
    Joshi, Nikhil
    Pawade, Tania
    Adamson, Philip
    Whiteley, William
    Wardlaw, Joanna
    Slomka, Piotr
    Williams, Michelle
    Newby, David
    Dweck, Marc
    HEART, 2021, 107 : A122 - A122
  • [26] CLINICAL SIGNIFICANCE OF THE ASSESSMENT OF VALVULAR CALCIFICATION USING 18F-SODIUM FLUORIDE POSITRON EMISSION TOMOGRAPHY
    Aoyama, Rie
    Suzuki, Ayumi
    Ishikawa, Joji
    Harada, Kazumasa
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 1405 - 1405
  • [27] 18F-SODIUM FLUORIDE POSITRON EMISSION TOMOGRAPHY IS A MARKER OF VASCULAR SHEAR STRESS AND AORTIC ATHEROSCLEROSIS
    Jenkins, W.
    Waddell, J.
    Vesey, A.
    Joshi, N.
    Rudd, J.
    Newby, D.
    Dweck, M.
    ATHEROSCLEROSIS, 2015, 241 (01) : E48 - E49
  • [28] 18F-Sodium fluoride positron emission tomography, aortic disease activity and ischaemic stroke risk
    Fletcher, A.
    Tzolos, E.
    Joshi, S.
    Kwiecinski, J.
    Bing, R.
    Doris, M. K.
    Moss, A. J.
    Van Beek, E. J.
    Joshi, N.
    Adamson, P.
    Whiteley, W.
    Wardlaw, J.
    Slomka, P.
    Newby, D. E.
    Dweck, M. R.
    EUROPEAN HEART JOURNAL, 2021, 42 : 1991 - 1991
  • [29] 18F-Sodium Fluoride Positron Emission Tomography for Molecular Imaging of Coronary Atherosclerosis Based on Computed Tomography Analysis
    Kitagawa, Toshiro
    Yamamoto, Hideya
    Toshimitsu, Shinya
    Sasaki, Ko
    Senoo, Atsuhiro
    Hirokawa, Yutaka
    Kihara, Yasuki
    CIRCULATION, 2016, 134
  • [30] 18F-Sodium Fluoride Positron Emission Tomography for Molecular Imaging of Coronary Atherosclerosis Based on Computed Tomography Analysis
    Kitagawa, Toshiro
    Yamamoto, Hideya
    Toshimitsu, Shinya
    Sasaki, Ko
    Senoo, Atsuhiro
    Hirokawa, Yutaka
    Kihara, Yasuki
    CIRCULATION, 2016, 134